CAC 40 Closes Lower: Fed Rekindles Fears of Further Rate Hikes
A Session Dampened by Hawkish Monetary Rhetoric
The « why now » of this session is unfolding across the Atlantic. The minutes from the latest Federal Reserve meeting, released the day before, revealed that « almost all » officials consider a further rate hike likely if inflation remains high. Several speeches, including one by Governor Christopher Waller, even mentioned the possibility of a 50 basis points increase in December. This could deter investors who are already cautious.
The trend can be observed across Europe. The DAX fell by 1.06% and the STOXX 600 by 0.88% at the close, while the FTSE 100 dropped 0.93%. On Wall Street, nerves were still evident at the time of the Paris close: the Dow Jones was down 1.85%, the S&P 500 was down 1.64%, and the Nasdaq 100 was down 1.77%. The VIX volatility index jumped nearly 9%, reaching around 26.76 points, indicating increased tension.
Luxury and Semiconductors Save a Few Points
In this bleak setting, the few increases came from the luxury and technology sectors. STMicroelectronics posted the best performance on the index, rising 1.59% to 41.17 euros. The Franco-Italian chip manufacturer outpaced major luxury names: LVMH gained 0.98% to 391.90 euros, and Kering 0.82% to 179.32 euros.
Eurofins Scientific (+0.71%) and Thales (+0.66%) round out the leading group. The defense company announced Thursday the signing of two memorandums of understanding with the Malaysian conglomerate Weststar, focusing on sovereign space capabilities, anti-drone defense, and cybersecurity. These are currently frameworks for cooperation.
Accor, Sanofi, and Tech in the Red
The list of declines is extensive and the dispersion telling: only one stock remained stable. Accor closed the session, dropping 3.12% to €48.73. The hotel group has signed an agreement to acquire the minority shares of Ennismore for €1.6 billion by 2028. At the same time, CIC Market Solutions downgraded its rating from buy to hold, while maintaining its price target.
Sanofi fell by 2.85% to €83.79, despite receiving European approval for VaxRabeo, its new rabies vaccine. The European Commission granted its first marketing authorization, covering pre- and post-exposure prophylaxis for all age groups.
Technology and growth stocks, sensitive to the prolonged high-rate scenario, also suffered: Capgemini lost 2.68% and EssilorLuxottica 2.21%. Danone dropped 2% to €67.78. In the background, confirmation of a 4.0% inflation rate in the eurozone in October and a ten-year French government bond yield close to 4.9% continue to fuel caution. In the energy sector, Brent crude ended the previous day around $92 a barrel, declining as the buildup of U.S. stocks outweighed persistent tensions in the Strait of Hormuz.
This content has been automatically translated using artificial intelligence. While we strive for accuracy, some nuances may differ from the original French version.